Skip to content

Clinical trials

Metabolism, Inborn Errors trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Metabolism, Inborn Errors Country / region: Germany Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20092
20141
20152
20171
20182
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Terminated2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Regeneron Pharmaceuticals2
Alexion Pharmaceuticals, Inc.1
Alnylam Pharmaceuticals1
CENTOGENE GmbH Rostock1
Shire1
Sumitomo Pharma Switzerland GmbH1
SwanBio Therapeutics, Inc.1
medac GmbH1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Metabolism, Inborn Errors9
Genetic Diseases, Inborn7
Metabolic Diseases7
Lysosomal Storage Diseases4
Brain Diseases, Metabolic, Inborn3
Lipid Metabolism Disorders3
Musculoskeletal Diseases3
Arthritis2
Brain Diseases2
Brain Diseases, Metabolic2

Trials

Showing 26 to 9 of 9. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.